Approved Study Database

Ref. No. Scientific Title Principal investigator
2007.308 Multi-Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of DU-176b in Chinese Healthy Male Adult Subjects Prof. Briant Tomlinson
2007.307 A Phase 2, Randomized, Parallel Group, Multi-Center, Multi-National Study for the Evaluation of Safety and Efficacy of Two Fixed Dosages of DU-176b in Subjects with Non-Valvular Atrial Fibrillation Prof. Yu Cheuk Man
2007.304 The Effectiveness of a Structured Home Blood Pressure Monitoring Programme at Primary Care: A Cluster Randomized Controlled Trial Prof. Fung Siu Cheung Colman
2007.301 Augmentation for Healing of Acute Clavicular Fracture with LIPUS Dr. Lam Tsz Ping
2007.300 A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis Prof. Charles David GOMERSALL
2007.292 A Randomized, Double-Blind, Pilot Study Comparing the Saftey and Efficacy of Betamare Plus Chemotherapy to Chemotherapy Alone in the Prevention and Treatment of Cancer Anorexia and Cachexia in Patients with Advanced Non-Small Cell Lung Cancer Dr. Lam Kwok Chi
2007.288 Use of Niacin for Erectile Dysfunction in Patients with Concomitant Hyperlipidaemia Dr. Lee Chui Ping
2007.284 Chronic Disease Self-Management Program (CDSMP) For Care of Older Persons: A Controlled Trial Prof. Hui Elsie
2007.282 A Multicenter, Randomized, Double-Blind, Prof. Yu Cheuk Man
2007.281 A Comparative Pharmacokinetic Study of Cilostazol SR Capsule with Pletaal Tablet in Healthy Male Subjects Prof. Brian Tomlinson
2007.278 Clinical Bioequivalence Study on Two Diazepam Formulations Prof. Lee HL Vincent
2007.277 Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM-IBS) Prof. Chan K.L. Francis
2007.273 A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose-Range Finding Study of MK-0893 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control Dr. Ma Ronald
2007.272 A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients with Sarcopenia Prof. Woo Jean
2007.271 A Multicenter, Randomized, Double-Blind, Prof. Brian Tomlinson
2007.268 Efficacy and Safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: A One Year, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study Prof. Wing Yun Kwok
2007.267 Prospective Trial of a Herbal Formula BYSH and Saw Palmetto in Patients with Hormonal Refractory Prostate Cancer Prof. Ng Chi Fai
2007.261 The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria Prof. Szeto Cheuk Chun
2007.251 Self Expandable Metal Stent (SEMS) Against Combined Brachytherapy and External Radiotherapy for Palliation of Advanced Oesophageal Cancer Prof. Chiu Wai Yan Philip
2007.249 Multi-Center, Double-blind, Randomized, Placebo-Controlled, Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of the DPP-IV Inhibitor RO4876904 in Patients with Type 2 Diabetes Prof. Kong P.S. Alice
2007.248 An International, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (> 16 to 70 years old) Suffering From Localization-Related or Generalized Epilepsy Dr. Kwan Patrick
2007.247 An Open-Label Multicenter Study Administering Lapatinib and Capecitabine (Xeloda) in Women with Advanced or Metastatic Breast Cancer Prof. Yeo Winnie
2007.246 A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer Prof. MOK Tony SK
2007.245 Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of the DPP-IV Inhibitor RO4876904 in Patients with Type 2 Diabetes Prof. Brian Tomlinson
2007.244 Clinical Bioequivalence Study on Two Acarbose Formulations Prof. Brian Tomlinson
2007.243 12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients with Overactive Bladder Prof. Ng Chi Fai
2007.242 An Open-Label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects with Schizophrenia Dr. Chung Wai Sau Dicky
2007.241 An Open-Label Phase I/II Study to Assess the Safety and Immunogenicity of Two Doses of a Vero Cell-Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Volunteers Aged 21 to 45 Years Prof. Hui SC David
2007.239 Evaluation of the T-SPOT, TB and QuantiFERON-TB Gold Test in the Targeted Screening of Latent Tuberculosis Infection among Patients Receiving or Going to Receive Immunocompromised Patients in Hong Kong Prof. Tam Lai Shan
2007.231 Evaluation of the Impact of Diabetes on the Quality of Life of Elderly Chinese People in Hong Kong Ms. Tung Yuk Wah
2007.230 A Phase 2, Multicenter, Open Label, Randomized Trial of AMG 706 or Bevacizumab in Combination with Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer Prof. Mok S.K. Tony
2007.229 A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus Prof. Chan LY Henry
2007.228 A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus Prof. Chan LY Henry
2007.227 A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus Dr. Leung WY Nancy
2007.226 A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Na_ve Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus Dr. Leung WY Nancy
2007.222 Effects of Orlistat With or Without Strength Training on Physical Fitness and Endothelial Function of Obese Adolescents Prof. Li Albert Martin
2007.219 A Pilot Study on Vibration Therapy for Osteopenia and Balance Control in Girls with Adolescent Idiopathic Scoliosis (AIS) Prof. Cheng J.C.Y.
2007.206 A Comparative Study of Entecavir vs Adefovir plus Lamivudine vs Combination Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study Prof. Chan Lik Yuen Henry
2007.201 Comparison of Various Lodoz / Angiotensin Receptor Blocker Combination Regimens in the Treatment of Hypertension Prof. TOMLINSON Brian
2007.200 An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Prof. Mok S.K. Tony
2007.199 An Open-Label, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) Prof. Yeo Winnie
2007.198 A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer Prof. CHAN Anthony T. C.
2007.197 A Multi-Centre, Randomized, Controlled Study of External CounterPulsation for Patients with Recent Atherosclerotic Stroke Prof. WONG Lawrence Ka Sing
2007.196 Overcoming Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Management of Advanced Stage Non-Small Cell Lung Cancer Prof. Mok Tony
2007.195 The Implementation and Evaluation of a Cognitive-Behavioral Randomized Controlled HIV Intervention Prevention Trial for at-Risk Monogamous Chinese Women Attending Public STD Clinics in Hong Kong Prof. Lau T.F. Joseph
2007.194 Randomized Trial Comparing A Novel Physical Antimicrobial Dressing Aerosal (Jieyoushen) With Placebo in Prevention of Catheter Associated Urinary Tract Infection in Chinese Patients with Urethral Catheter Secondary to Acute Retention of Urine Prof.. Ng Chi Fai
2007.186 A Phase 3, Randomized, Double-Blind, Parallel-Group, Multi-Center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely I11 Medical Subjects During and Following Hospitalization Dr. Wong Siu Ming Raymond
2007.185 A Randomized, Crossover Study of Medroxyprogesterone Acetate and Diane-35 on Polycystic Ovarian Syndrome Adolescents Dr. Chan Shing Chee Symphorosa
2007.183 A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Dose-Response Study of Rivoglitazone (CS-011) in Patients with Type 2 Diabetes Prof. Kong P.S. Alice
2007.180 A Phase 3, Multi-Center, Randomized Double-Blind, Placebo-Controlled 52 Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B Prof. Li Kwok Ming Edmund

Page 238 of 254.